The Hidden Cost of Waiting
What pharma brands lose in 6-month production cycles, and why the math is changing.
Benji
Founder
When pharma marketers evaluate video production, they focus on the obvious costs: agency fees, production budgets, media spend. These are the numbers that appear in budget spreadsheets and procurement discussions.
But the largest cost of traditional production doesn't appear on any invoice. It's the cost of waiting.
A typical pharma video production takes 3-6 months from concept to delivery. During that time, markets move, competitors launch, access decisions happen, and patient needs evolve. Your campaign, locked in production, can't respond.
This isn't just inconvenient. It's expensive in ways that are hard to quantify but impossible to ignore.
Consider what happens when a competitor launches a new product while you're mid-production. By the time your original campaign is ready, the market conversation has changed. Your messaging, developed months ago, may no longer address what patients and HCPs are actually discussing.
Or consider the cost of untested creative hypotheses. Traditional production forces you to commit significant budget to one creative direction before you have any real-world performance data. You're making a big bet based on research and intuition, hoping you've guessed right.
The compounding value of iteration and learning is lost entirely. Every month you wait is a month you're not learning what actually resonates with your audience. That learning compounds over time. Teams that iterate faster don't just produce more content. They produce better content, because they learn faster what works.
There's also the strategic cost of reduced optionality. When production is slow and expensive, you can only pursue a limited number of creative directions. You have to choose your bets carefully and live with them for extended periods.
When production is fast and affordable, you can explore more options. You can test multiple approaches simultaneously. You can respond to what you learn. You have options that slower competitors simply don't have.
The math of pharma marketing is changing. Speed isn't just efficiency. It's optionality. And optionality has enormous strategic value in a market that moves faster than traditional production timelines allow.
ohohoh.ai enables the speed that unlocks this optionality. Complete ads in hours, not months. Test multiple variants before committing. React to market moments as they happen. The hidden cost of waiting becomes a competitive advantage you no longer have to pay.
Continue reading
MLR Doesn't Have to Be the Bottleneck
Why the fastest pharma teams treat compliance as a creative accelerator, not a roadblock.
When a Competitor Launches, What's Your Plan?
The pharma teams that win aren't faster at reacting. They're ready to react at all.
Curious to learn more?
We can show you all the ways ohohoh.ai can unlock your brand's potential.
Ask for a Demo